Radiation Oncology/Therapy: Page 40

PET reduces radiation therapy dose for throat cancer

By AuntMinnie.com staff writers

PET scans acquired before and midway through radiation therapy in patients with throat cancer can help determine whether therapy can be reduced in the second half of treatment, according to a study presented February 24 at an American Society for Radiation Oncology symposium in Phoenix.

February 27, 2022

FDA clears Theragnostics kidney agent NephroScan

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared for market the NephroScan technetium-99m (Tc-99m) radiodiagnostic imaging agent from radiopharmaceuticals firm Theragnostics.

February 22, 2022

Mevion lands proton therapy order in China

By AuntMinnie.com staff writers

Mevion Medical Systems has received an order from Tongji Hospital in Wuhan, China.

February 21, 2022

Accuray signs Royal Brisbane in Australia

By AuntMinnie.com staff writers

Radiation therapy firm Accuray has received an order from Royal Brisbane and Women's Hospital in Queensland, Australia.

February 15, 2022

MIM Software partners with AMG Medtech

By AuntMinnie.com staff writers

Medical imaging software developer MIM Software has formed a partnership with AMG Medtech, a U.K.-based consultancy firm and distributor.

February 14, 2022

Elekta posts 3% decline in Q3 revenues

By AuntMinnie.com staff writers

Radiation oncology firm Elekta posted a 3% decline in revenue after currency adjustment for its third quarter, which it attributed to supply chain challenges.

February 13, 2022

Radiation therapy increases heart attack risk in lung cancer patients

By Kate Madden Yee

Thoracic radiation therapy increases the risk of heart disease, heart attack, or stroke in lung cancer patients who have high levels of coronary artery calcium on chest CT, according to researchers from Washington University in St. Louis, MO.

February 13, 2022

ViewRay wins MRIdian order in Germany

By AuntMinnie.com staff writers

Image-guided radiation therapy developer ViewRay will be installing its MRIdian MRI-guided radiation therapy system at the Krukenberg Cancer Center in Germany.

February 10, 2022

Theragnostics receives U.K. MHRA Innovation Passport

By AuntMinnie.com staff writers

Radiopharmaceuticals firm Theragnostics has been awarded an Innovation Passport by the U.K. Medicines and Healthcare products Regulatory Agency for its THG-009 iodine-123 poly polymerase inhibitor radiotherapeutic agent.

February 10, 2022

Shine and Telix ink Lu-177 supply deal

By AuntMinnie.com staff writers

Medical isotope company Shine Technologies and Telix Pharmaceuticals have signed an agreement covering the supply of lutetium-177 (Lu-177) to Telix for clinical development of potential new therapeutics to treat prostate and kidney cancer.

February 9, 2022

Mevion, Proton secure Texas contract

By AuntMinnie.com staff writers

Mevion Medical Systems has partnered with Proton International to provide Mevion's compact proton therapy technology to a new proton therapy and research center at the University of Texas in San Antonio.

February 8, 2022

Curie Therapeutics taps new CTO

By AuntMinnie.com staff writers

Curie Therapeutics has appointed Bernard Lambert, PhD, as its new chief technology officer (CTO).

February 6, 2022

Previous Page

Page 40 of 468

Next Page